Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eton Pharmaceutcials Inc (NQ: ETON )

10.97 +0.22 (+2.05%)
Streaming Delayed Price Updated: 10:14 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eton Pharmaceutcials Inc

< Previous 1 2 3 4 5 Next >
Analyst Expectations For Eton Pharmaceuticals's Future
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For Eton Pharmaceuticals
Via Benzinga
Critical Insights From Eton Pharmaceuticals Analyst Ratings: What You Need To Know
Via Benzinga
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
Should investors add these stocks on their watchlist? Insider buys suggest so. 
Via Talk Markets
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Recap: Eton Pharmaceuticals Q4 Earnings
Via Benzinga
Eton Pharmaceuticals Earnings Preview
Via Benzinga
Is NASDAQ:ETON suited for growth investing?
ETON PHARMACEUTICALS INC (NASDAQ:ETON) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
ETON stock results show that Eton Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Gilead Sciences Tops Q3 Earnings And Revenue Estimates
While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Why the growth investor may take a look at NASDAQ:ETON.
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
Via Chartmill
Evaluating NASDAQ:ETON for Growth Investment Opportunities.
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
Via Chartmill
Eton Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
FSR Stock Alert: What to Know About the New Fisker Ronin EV
Fisker (FSR) stock is in the news Friday after the company provided customers with more details about the upcoming Fisker Ronin Super GT EV. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Cano Health (CANO) Stock Down 48% Today?
Cano Health (CANO) stock is taking a beating on Friday after the healthcare company provided a business update in its latest earnings report. 
Via InvestorPlace
Why is Yield10 Bioscience (YTEN) Stock Down 46% Today?
Yield10 Bioscience (YTEN) stock is falling hard on Friday with heavy trading after a public share offering went into effect. 
Via InvestorPlace
Why Semler Scientific Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?
Eton Pharmaceuticals (ETON) stock is soaring following the release of its earnings report for the second quarter of 2023! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Wells Fargo To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday
Jefferies boosted the price target for ACM Research, Inc. (NASDAQ: ACMR) from $9 to $23.4. Jefferies analyst Nick Cheng upgraded the stock from Underperform to Buy. ACM Research shares fell 2.2% to... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.